KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organon (OGN) Debt to Equity (2020 - 2025)

Organon has reported Debt to Equity over the past 6 years, most recently at $11.49 for Q4 2025.

  • Quarterly results put Debt to Equity at $11.49 for Q4 2025, down 38.9% from a year ago — trailing twelve months through Dec 2025 was $11.49 (down 38.9% YoY), and the annual figure for FY2025 was $11.49, down 38.9%.
  • Debt to Equity for Q4 2025 was $11.49 at Organon, up from $9.74 in the prior quarter.
  • Over the last five years, Debt to Equity for OGN hit a ceiling of $181.54 in Q1 2024 and a floor of -$125.14 in Q4 2023.
  • Median Debt to Equity over the past 5 years was -$5.28 (2021), compared with a mean of $5.56.
  • Biggest five-year swings in Debt to Equity: plummeted 2581.62% in 2021 and later skyrocketed 1635.95% in 2024.
  • Organon's Debt to Equity stood at -$6.06 in 2021, then tumbled by 64.97% to -$9.99 in 2022, then plummeted by 1152.41% to -$125.14 in 2023, then soared by 115.03% to $18.81 in 2024, then plummeted by 38.9% to $11.49 in 2025.
  • The last three reported values for Debt to Equity were $11.49 (Q4 2025), $9.74 (Q3 2025), and $12.14 (Q2 2025) per Business Quant data.